首页 > 最新文献

Clinical and Experimental Hypertension最新文献

英文 中文
Efficacy of using walnuts as statin adjuvants in hypertension management 核桃作为他汀类药物辅助治疗高血压的疗效观察
IF 12.3 4区 医学 Q3 Medicine Pub Date : 2022-04-17 DOI: 10.1080/10641963.2022.2065287
P. Amadi, E. Agomuo, J. Amadi, A.I. Bob-Chile Agada, U. Njoku, Chinedu S Ogunwa, Prince C. Odika, J. O. Osuoha, A. Ogbolosingha, Chiamaka Adumekwe, I. N. Chigbu
ABSTRACT Background Due to the widespread unorthodox use of nuts to improve cardiovascular health, this clinical trial was carried out to evaluate the efficacy of walnut as an adjuvant statin in hypertensive subjects. Method A single-blind placebo-controlled randomized clinical trial that lasted for 3 months. Forty-five screened hypertensive subjects on treatment, aged 45–65 years, were randomized into intervention and placebo groups according to their blood pressure defined by the American Heart Association criteria. Fifteen (15) normotensive subjects were also recruited for this study. The participants in the intervention group included daily 7 g of boiled walnut taken as snacks. The study was not controlled for type of diet and frequency of meals in a day. Low-density lipoprotein cholesterol (LDLc) was the primary endpoint for this study. Results The mean LDLc levels of the intervention groups (84.6 mg/dl and 79.7 mg/dl, respectively) were significantly (p < .005) lower than the placebo (137.6 mg/dl). The high-density lipoprotein cholesterol (HDLc) levels of the intervention groups were significantly higher than the placebo. The mean total cholesterol levels of the intervention groups were significantly lower than the placebo group. The intervention groups recorded a significantly lower systolic and diastolic blood pressure compared to the placebo. The supplementation of walnut significantly decreased the apolipoprotein E (APOE), proprotein convertase subtilisin kexin 9 (PCSK9), and cholesteryl ester transfer protein (CETP) activities relative to the placebo. Conclusion The use of walnut as a statin adjuvant during hypertension treatment reduced LDLc levels within 42.1% and improved HDL levels by 33.6%, and the LDLc decrease related to reduced PCSK9 and APOE activities while the HDLc increase related to reduced CETP activities.
背景:由于坚果被广泛用于改善心血管健康,本临床试验旨在评估核桃作为他汀类药物辅助治疗高血压患者的疗效。方法采用单盲安慰剂对照随机临床试验,为期3个月。45名年龄在45-65岁之间的高血压患者根据美国心脏协会的血压标准被随机分为干预组和安慰剂组。本研究还招募了15名血压正常的受试者。干预组的参与者每天吃7克煮核桃作为零食。这项研究没有控制饮食类型和一天中吃饭的频率。低密度脂蛋白胆固醇(LDLc)是这项研究的主要终点。结果干预组的平均ldl水平分别为84.6 mg/dl和79.7 mg/dl,显著低于安慰剂组(137.6 mg/dl) (p < 0.005)。干预组的高密度脂蛋白胆固醇(HDLc)水平明显高于安慰剂组。干预组的平均总胆固醇水平明显低于安慰剂组。与安慰剂组相比,干预组的收缩压和舒张压明显降低。与安慰剂相比,核桃的添加显著降低了载脂蛋白E (APOE)、蛋白转化酶枯草杆菌蛋白9 (PCSK9)和胆固醇酯转移蛋白(CETP)的活性。结论在高血压治疗过程中,核桃作为他汀类药物的辅助剂,ldl水平降低42.1%以内,HDL水平提高33.6%,ldl降低与PCSK9和APOE活性降低有关,HDL升高与CETP活性降低有关。
{"title":"Efficacy of using walnuts as statin adjuvants in hypertension management","authors":"P. Amadi, E. Agomuo, J. Amadi, A.I. Bob-Chile Agada, U. Njoku, Chinedu S Ogunwa, Prince C. Odika, J. O. Osuoha, A. Ogbolosingha, Chiamaka Adumekwe, I. N. Chigbu","doi":"10.1080/10641963.2022.2065287","DOIUrl":"https://doi.org/10.1080/10641963.2022.2065287","url":null,"abstract":"ABSTRACT Background Due to the widespread unorthodox use of nuts to improve cardiovascular health, this clinical trial was carried out to evaluate the efficacy of walnut as an adjuvant statin in hypertensive subjects. Method A single-blind placebo-controlled randomized clinical trial that lasted for 3 months. Forty-five screened hypertensive subjects on treatment, aged 45–65 years, were randomized into intervention and placebo groups according to their blood pressure defined by the American Heart Association criteria. Fifteen (15) normotensive subjects were also recruited for this study. The participants in the intervention group included daily 7 g of boiled walnut taken as snacks. The study was not controlled for type of diet and frequency of meals in a day. Low-density lipoprotein cholesterol (LDLc) was the primary endpoint for this study. Results The mean LDLc levels of the intervention groups (84.6 mg/dl and 79.7 mg/dl, respectively) were significantly (p < .005) lower than the placebo (137.6 mg/dl). The high-density lipoprotein cholesterol (HDLc) levels of the intervention groups were significantly higher than the placebo. The mean total cholesterol levels of the intervention groups were significantly lower than the placebo group. The intervention groups recorded a significantly lower systolic and diastolic blood pressure compared to the placebo. The supplementation of walnut significantly decreased the apolipoprotein E (APOE), proprotein convertase subtilisin kexin 9 (PCSK9), and cholesteryl ester transfer protein (CETP) activities relative to the placebo. Conclusion The use of walnut as a statin adjuvant during hypertension treatment reduced LDLc levels within 42.1% and improved HDL levels by 33.6%, and the LDLc decrease related to reduced PCSK9 and APOE activities while the HDLc increase related to reduced CETP activities.","PeriodicalId":10333,"journal":{"name":"Clinical and Experimental Hypertension","volume":null,"pages":null},"PeriodicalIF":12.3,"publicationDate":"2022-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90581815","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Blood Pressure and Blood Glucose Responses to Combined Exercise Sessions of Different Intensities in Individuals with Cardiovascular Risk Factors 有心血管危险因素个体不同强度联合运动对血压和血糖的反应
IF 12.3 4区 医学 Q3 Medicine Pub Date : 2022-04-14 DOI: 10.1080/10641963.2022.2065289
Mabel Diesel, Isabel Heberle, G. Juchem, Guilherme Tadeu de Barcelos, Juliana Cavestré Coneglian, A. Gerage, R. S. Delevatti
ABSTRACT Objective The purpose of the present study was to verify the acute effects of blood pressure and blood glucose after two sessions of combined exercise sessions performed at two levels of intensity in trained individuals with cardiovascular risk factors. Methods Eighteen individuals (66.22 ± 8.61 years) of both sexes (6 women/12 men) with cardiovascular risk factors performed two sessions of combined exercises at different levels of intensity: moderate (MOD) and high (HI). To control the intensity of the aerobic training, the Borg Rating of Perceived Exertion (RPE) Scale was used. For the strength training, the maximum number of repetitions was carried out within a predetermined duration of sets. Blood pressure and blood glucose measurements were collected before and 20 minutes after the sessions. The data were analyzed using Generalized Estimating Equations, α 5%. Results Reductions were observed in systolic blood pressure (MOD – Δ = −4.95 mmHg; HI – Δ = −3.31 mmHg) and blood glucose (MOD – Δ = −16.06 mg/dL; HI – Δ = −29.45 mg/dL) after the two sessions, with no difference between sessions. Diastolic blood pressure did not change (p < .05). Conclusion Combined exercises sessions of moderate or high intensity can promote an acute reduction in systolic blood pressure and glycemia in individuals with cardiovascular risk factors.
【摘要】目的本研究的目的是验证具有心血管危险因素的训练个体在两种强度下进行两次联合运动后对血压和血糖的急性影响。方法有心血管危险因素的18例男女(66.22±8.61岁)(6女12男)分别进行中等(MOD)和高(HI)两组不同强度的组合运动。为了控制有氧训练的强度,采用Borg感知运动强度评分(RPE)量表。对于力量训练,最大次数的重复是在预定的时间内进行的。在训练前和训练后20分钟采集血压和血糖测量值。用α 5%的广义估计方程对数据进行分析。结果收缩压降低(MOD - Δ = - 4.95 mmHg;HI - Δ =−3.31 mmHg)和血糖(MOD - Δ =−16.06 mg/dL;HI - Δ =−29.45 mg/dL),两组间无差异。舒张压无明显变化(p < 0.05)。结论中等或高强度的联合运动可促进心血管危险因素患者收缩压和血糖的急性降低。
{"title":"Blood Pressure and Blood Glucose Responses to Combined Exercise Sessions of Different Intensities in Individuals with Cardiovascular Risk Factors","authors":"Mabel Diesel, Isabel Heberle, G. Juchem, Guilherme Tadeu de Barcelos, Juliana Cavestré Coneglian, A. Gerage, R. S. Delevatti","doi":"10.1080/10641963.2022.2065289","DOIUrl":"https://doi.org/10.1080/10641963.2022.2065289","url":null,"abstract":"ABSTRACT Objective The purpose of the present study was to verify the acute effects of blood pressure and blood glucose after two sessions of combined exercise sessions performed at two levels of intensity in trained individuals with cardiovascular risk factors. Methods Eighteen individuals (66.22 ± 8.61 years) of both sexes (6 women/12 men) with cardiovascular risk factors performed two sessions of combined exercises at different levels of intensity: moderate (MOD) and high (HI). To control the intensity of the aerobic training, the Borg Rating of Perceived Exertion (RPE) Scale was used. For the strength training, the maximum number of repetitions was carried out within a predetermined duration of sets. Blood pressure and blood glucose measurements were collected before and 20 minutes after the sessions. The data were analyzed using Generalized Estimating Equations, α 5%. Results Reductions were observed in systolic blood pressure (MOD – Δ = −4.95 mmHg; HI – Δ = −3.31 mmHg) and blood glucose (MOD – Δ = −16.06 mg/dL; HI – Δ = −29.45 mg/dL) after the two sessions, with no difference between sessions. Diastolic blood pressure did not change (p < .05). Conclusion Combined exercises sessions of moderate or high intensity can promote an acute reduction in systolic blood pressure and glycemia in individuals with cardiovascular risk factors.","PeriodicalId":10333,"journal":{"name":"Clinical and Experimental Hypertension","volume":null,"pages":null},"PeriodicalIF":12.3,"publicationDate":"2022-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84959219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inter-arm blood pressure difference is associated with contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention. st段抬高型心肌梗死患者行原发性经皮冠状动脉介入治疗后,臂间血压差与造影剂肾病相关。
IF 12.3 4区 医学 Q3 Medicine Pub Date : 2022-04-03 Epub Date: 2022-01-21 DOI: 10.1080/10641963.2022.2029471
Zeki Simsek, Regayip Zehir, Sedat Kalkan, Doğancan Ceneli, Elnur Alizade, Emrah Bayam, Özkan Candan

Objective: Contrast-induced nephropathy (CIN) is a serious complication in patients with ST segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (p-PCI). An interarm systolic blood pressure difference (IASBD) ≥10 mmHg has been identified as an independent risk factor for cardiovascular disease and mortality. The aim of this study was to evaluate the predictive value of the IASBD for the risk of CIN in patients with STEMI who underwent p-PCI.

Method: We prospectively investigated 2120 consecutive patients who were hospitalized with a diagnosis of STEMI and underwent p-PCI. A relative increase in serum creatinine levels of ≥ 25% or an absolute increase of ≥ 0.5 mg/dL from baseline within 72 h of contrast exposure was defined as CIN. The IASBD was calculated on admission to the emergency department. The risk of CIN was evaluated.

Results: The incidence of CIN was 6.6% (n = 139). The patients were divided into 2 groups based on the development of CIN. Age (p = .001), baseline creatinine levels (p < .001), DM (p < .001), HT (p < .001) and anemia (p = .001) were higher in patients with CIN. An IASBD ≥10 mmHg was noted in 13 (9.3%) patients in the CIN group and 83 (4.1%) (p = .001) in the non-CIN group (Table 1). According to the multivariate analysis, the IASBD was found to be a predictor of CIN development (OR: 2.36, 95% CI: 1.42-3.90, p: 0.001).

Conclusion: The IASBD on admission can be a potential predictor of CIN development in patients with STEMI who underwent p-PCI.

目的:造影剂肾病(CIN)是ST段抬高型心肌梗死(STEMI)患者接受初级经皮冠状动脉介入治疗(p-PCI)的严重并发症。收缩压差(IASBD)≥10 mmHg已被确定为心血管疾病和死亡的独立危险因素。本研究的目的是评估IASBD对STEMI患者行p-PCI后发生CIN风险的预测价值。方法:我们前瞻性调查了2120例诊断为STEMI并接受p-PCI治疗的连续住院患者。对比剂暴露后72小时内血清肌酐水平相对增加≥25%或绝对增加≥0.5 mg/dL被定义为CIN。IASBD在进入急诊科时计算。评估CIN的风险。结果:CIN发生率为6.6% (n = 139)。根据CIN的发展情况将患者分为两组。结论:入院时的IASBD可作为STEMI患者行p- pci后CIN发展的潜在预测指标。
{"title":"Inter-arm blood pressure difference is associated with contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention.","authors":"Zeki Simsek,&nbsp;Regayip Zehir,&nbsp;Sedat Kalkan,&nbsp;Doğancan Ceneli,&nbsp;Elnur Alizade,&nbsp;Emrah Bayam,&nbsp;Özkan Candan","doi":"10.1080/10641963.2022.2029471","DOIUrl":"https://doi.org/10.1080/10641963.2022.2029471","url":null,"abstract":"<p><strong>Objective: </strong>Contrast-induced nephropathy (CIN) is a serious complication in patients with ST segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (p-PCI). An interarm systolic blood pressure difference (IASBD) ≥10 mmHg has been identified as an independent risk factor for cardiovascular disease and mortality. The aim of this study was to evaluate the predictive value of the IASBD for the risk of CIN in patients with STEMI who underwent p-PCI.</p><p><strong>Method: </strong>We prospectively investigated 2120 consecutive patients who were hospitalized with a diagnosis of STEMI and underwent p-PCI. A relative increase in serum creatinine levels of ≥ 25% or an absolute increase of ≥ 0.5 mg/dL from baseline within 72 h of contrast exposure was defined as CIN. The IASBD was calculated on admission to the emergency department. The risk of CIN was evaluated.</p><p><strong>Results: </strong>The incidence of CIN was 6.6% (n = 139). The patients were divided into 2 groups based on the development of CIN. Age (p = .001), baseline creatinine levels (p < .001), DM (p < .001), HT (p < .001) and anemia (p = .001) were higher in patients with CIN. An IASBD ≥10 mmHg was noted in 13 (9.3%) patients in the CIN group and 83 (4.1%) (p = .001) in the non-CIN group (Table 1). According to the multivariate analysis, the IASBD was found to be a predictor of CIN development (OR: 2.36, 95% CI: 1.42-3.90, p: 0.001).</p><p><strong>Conclusion: </strong>The IASBD on admission can be a potential predictor of CIN development in patients with STEMI who underwent p-PCI.</p>","PeriodicalId":10333,"journal":{"name":"Clinical and Experimental Hypertension","volume":null,"pages":null},"PeriodicalIF":12.3,"publicationDate":"2022-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39707008","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Serum irisin and adropin levels may be predictors for coronary artery ectasia. 血清鸢尾素和促肾上腺素水平可能是冠状动脉扩张的预测因子。
IF 12.3 4区 医学 Q3 Medicine Pub Date : 2022-04-03 Epub Date: 2022-01-07 DOI: 10.1080/10641963.2021.2018601
Bayram Ali Uysal, Mevlut Serdar Kuyumcu

Background: There is strong evidence that oxidative stress and inflammation may contribute to the coronary artery ectasia (CAE) pathophysiology. Recent studies have shown that serum irisin and adropin levels are associated with oxidative stress and inflammation. In the light of this information, we aimed to investigate the possible relationship between serum irisin, adropin levels and CAE.

Patients & methods: A total of 50 consecutive patients with CAE and 50 consecutive patients with normal coronary anatomy (NCA) were enrolled into the study. Serum irisin, adropin and other clinical parameters were compared between groups.

Results: Adropin (p < .001) and irisin (p < .001) levels were lower in the CAE group. Low adropin (p = .014) and irisin (p < .001) levels were detected as an independent risk factor for CAE in multiple regression analysis. Receiver operating characteristic curve analysis showed that serum adropin (p < .001) and irisin (p < .001) leves was significant predictor of CAE.

Conclusions: The results of this study showed that serum irisin and adropin level was lower in the CAE group than in the NCA group. Irisin and adropin could play a role in the pathogenesis of CAE.

背景:有强有力的证据表明,氧化应激和炎症可能与冠状动脉扩张(CAE)的病理生理有关。最近的研究表明,血清鸢尾素和促肾上腺素水平与氧化应激和炎症有关。根据这些信息,我们旨在探讨血清鸢尾素、adropin水平与CAE之间的可能关系。患者和方法:共50例连续CAE患者和50例连续冠状动脉解剖正常(NCA)患者入组研究。各组血清鸢尾素、adropin等临床指标比较。结果:Adropin (p p p = 0.014)和irisin (p p p p)的差异有统计学意义。结论:CAE组血清irisin和Adropin水平明显低于NCA组。鸢尾素和adropin可能参与CAE的发病机制。
{"title":"Serum irisin and adropin levels may be predictors for coronary artery ectasia.","authors":"Bayram Ali Uysal,&nbsp;Mevlut Serdar Kuyumcu","doi":"10.1080/10641963.2021.2018601","DOIUrl":"https://doi.org/10.1080/10641963.2021.2018601","url":null,"abstract":"<p><strong>Background: </strong>There is strong evidence that oxidative stress and inflammation may contribute to the coronary artery ectasia (CAE) pathophysiology. Recent studies have shown that serum irisin and adropin levels are associated with oxidative stress and inflammation. In the light of this information, we aimed to investigate the possible relationship between serum irisin, adropin levels and CAE.</p><p><strong>Patients & methods: </strong>A total of 50 consecutive patients with CAE and 50 consecutive patients with normal coronary anatomy (NCA) were enrolled into the study. Serum irisin, adropin and other clinical parameters were compared between groups.</p><p><strong>Results: </strong>Adropin (<i>p</i> < .001) and irisin (<i>p</i> < .001) levels were lower in the CAE group. Low adropin (<i>p</i> = .014) and irisin (<i>p</i> < .001) levels were detected as an independent risk factor for CAE in multiple regression analysis. Receiver operating characteristic curve analysis showed that serum adropin (<i>p</i> < .001) and irisin (<i>p</i> < .001) leves was significant predictor of CAE.</p><p><strong>Conclusions: </strong>The results of this study showed that serum irisin and adropin level was lower in the CAE group than in the NCA group. Irisin and adropin could play a role in the pathogenesis of CAE.</p>","PeriodicalId":10333,"journal":{"name":"Clinical and Experimental Hypertension","volume":null,"pages":null},"PeriodicalIF":12.3,"publicationDate":"2022-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39882443","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Cardiovascular protective effect of nano selenium in hypothyroid rats: protection against oxidative stress and cardiac fibrosis. 纳米硒对甲状腺功能减退大鼠的心血管保护作用:对氧化应激和心脏纤维化的保护作用。
IF 12.3 4区 医学 Q3 Medicine Pub Date : 2022-04-03 Epub Date: 2022-02-10 DOI: 10.1080/10641963.2022.2036994
Seyed Hamidreza Rastegar Moghaddam, Mahmoud Hosseini, Fereshteh Sabzi, Fatemeh Hojjati Fard, Narges Marefati, Farimah Beheshti, Majid Darroudi, Alireza Ebrahimzadeh Bideskan, Akbar Anaeigoudari

Background: Nano selenium (Nano Sel) has many therapeutic properties including antioxidant, anticancer, and anti-inflammatory actions.

Objective: Impacts of Nano Sel administration against cardiac fibrosis and heart and aorta tissue oxidative damage observed in hypothyroid rats were explored.

Methods: The animals were randomly grouped and treated as: 1) Control; 2) Propylthiouracil (PTU) in which PTU was added to the drinking water (0.05%) to induce hypothyroidism; 3-5) PTU-Nano Sel 50, PTU-Nano Sel 100, and PTU-Nano Sel 150 groups, which received daily PTU plus 50,100 or 150 µg/kg of Nano Sel for 6 weeks intraperitoneally. The heart and aorta tissues were removed under deep anesthesia and then biochemical parameters including malondialdehyde (MDA), total thiol groups, catalase (CAT), and superoxide dismutase (SOD), as well as cardiac fibrosis were assessed.

Results: Hypothyroidism induced by PTU was remarkably associated with myocardial hypertrophy and perivascular fibrosis in Masson's trichrome staining. Moreover, hypothyroidism increased MDA level, while it subtracted total thiol group content and activity of SOD and CAT. Treatment with Nano Sel recovered hypothyroidism-induced cardiac fibrosis in the histological assessment. Nano Sel also promoted CAT and SOD activity and thiol content, whereas alleviated MDA levels in the heart and aorta tissues.

Conclusion: Results propose that administration of Nano Sel exerts a protective role in the cardio vascular system via preventing cardiac fibrosis and inhibiting oxidative stress.

背景:纳米硒(Nano Sel)具有许多治疗特性,包括抗氧化、抗癌和抗炎作用。目的:探讨纳米硒对甲状腺功能减退大鼠心肌纤维化和心脏及主动脉组织氧化损伤的影响。方法:随机分组,实验组:1)对照组;2)丙基硫脲嘧啶(PTU),将PTU添加到饮用水中(0.05%)诱导甲状腺功能减退;3-5) PTU-Nano Sel 50、PTU-Nano Sel 100和PTU-Nano Sel 150组,每天腹腔注射PTU加50,100或150µg/kg纳米Sel,持续6周。在深度麻醉下切除心脏和主动脉组织,评估丙二醛(MDA)、总巯基、过氧化氢酶(CAT)、超氧化物歧化酶(SOD)等生化指标及心肌纤维化情况。结果:马氏三色染色显示PTU诱导的甲状腺功能减退与心肌肥大和血管周围纤维化有显著相关性。甲状腺功能减退使MDA水平升高,使总硫醇组含量降低,SOD、CAT活性降低。用纳米Sel治疗甲状腺功能减退引起的心脏纤维化的组织学评估。纳米Sel还能提高CAT、SOD活性和硫醇含量,降低心脏和主动脉组织MDA水平。结论:纳米Sel通过预防心肌纤维化和抑制氧化应激对心血管系统具有保护作用。
{"title":"Cardiovascular protective effect of nano selenium in hypothyroid rats: protection against oxidative stress and cardiac fibrosis.","authors":"Seyed Hamidreza Rastegar Moghaddam,&nbsp;Mahmoud Hosseini,&nbsp;Fereshteh Sabzi,&nbsp;Fatemeh Hojjati Fard,&nbsp;Narges Marefati,&nbsp;Farimah Beheshti,&nbsp;Majid Darroudi,&nbsp;Alireza Ebrahimzadeh Bideskan,&nbsp;Akbar Anaeigoudari","doi":"10.1080/10641963.2022.2036994","DOIUrl":"https://doi.org/10.1080/10641963.2022.2036994","url":null,"abstract":"<p><strong>Background: </strong>Nano selenium (Nano Sel) has many therapeutic properties including antioxidant, anticancer, and anti-inflammatory actions.</p><p><strong>Objective: </strong>Impacts of Nano Sel administration against cardiac fibrosis and heart and aorta tissue oxidative damage observed in hypothyroid rats were explored.</p><p><strong>Methods: </strong>The animals were randomly grouped and treated as: 1) Control; 2) Propylthiouracil (PTU) in which PTU was added to the drinking water (0.05%) to induce hypothyroidism; 3-5) PTU-Nano Sel 50, PTU-Nano Sel 100, and PTU-Nano Sel 150 groups, which received daily PTU plus 50,100 or 150 µg/kg of Nano Sel for 6 weeks intraperitoneally. The heart and aorta tissues were removed under deep anesthesia and then biochemical parameters including malondialdehyde (MDA), total thiol groups, catalase (CAT), and superoxide dismutase (SOD), as well as cardiac fibrosis were assessed.</p><p><strong>Results: </strong>Hypothyroidism induced by PTU was remarkably associated with myocardial hypertrophy and perivascular fibrosis in Masson's trichrome staining. Moreover, hypothyroidism increased MDA level, while it subtracted total thiol group content and activity of SOD and CAT. Treatment with Nano Sel recovered hypothyroidism-induced cardiac fibrosis in the histological assessment. Nano Sel also promoted CAT and SOD activity and thiol content, whereas alleviated MDA levels in the heart and aorta tissues.</p><p><strong>Conclusion: </strong>Results propose that administration of Nano Sel exerts a protective role in the cardio vascular system via preventing cardiac fibrosis and inhibiting oxidative stress.</p>","PeriodicalId":10333,"journal":{"name":"Clinical and Experimental Hypertension","volume":null,"pages":null},"PeriodicalIF":12.3,"publicationDate":"2022-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39610507","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Influence of FOXP3 gene polymorphisms on the risk of preeclampsia: a meta-analysis and a bioinformatic approach. FOXP3基因多态性对子痫前期风险的影响:荟萃分析和生物信息学方法
IF 12.3 4区 医学 Q3 Medicine Pub Date : 2022-04-03 Epub Date: 2022-01-11 DOI: 10.1080/10641963.2021.2022685
Mohammad Karimian, Saeedeh Ghazaey Zidanloo, Danial Jahantigh

Background and aim: Preeclampsia (PE), a multifactorial disorder, is the main cause of maternal mortality and morbidity. Genetic polymorphisms in key proteins involved in the immune system may change the risk of PE risk. In this study, we examined the association of two rs2232365 and rs3761548 common polymorphisms of the FOXP3 immune response gene with PE susceptibility by a meta-analysis which was followed by an in-silico analysis.

Materials and methods: Through a systematic search in databases including PubMed, MEDLINE, Google Scholar, and Science Direct, we find eligible studies for meta-analysis. Some bioinformatics tools were used to detect the impact of rs2232365 and rs3761548 polymorphisms on the FOXP3 gene function.

Results: Our data revealed that there is a significant association between rs3761548 polymorphism and decreased risk of PE. In addition, we observed a significant association between rs2232365 and increased risk of mild preeclampsia. Also, our bioinformatic analysis showed that both rs2232365 and rs3761548 polymorphisms could affect FOXP3 gene function.

Conclusion: Based on our findings, the rs3761548 genetic variation could be a protective factor against PE risk. While the rs2232365 polymorphism may be a genetic risk factor for mild preeclampsia. Therefore, as a preliminary study, these genetic variations could be considered molecular biomarkers for PE disorder.

背景与目的:先兆子痫(PE)是一种多因素疾病,是孕产妇死亡和发病的主要原因。参与免疫系统的关键蛋白的遗传多态性可能改变PE风险。在这项研究中,我们通过荟萃分析和计算机分析,研究了FOXP3免疫反应基因的两个rs2232365和rs3761548常见多态性与PE易感性的关系。材料和方法:通过系统检索PubMed、MEDLINE、Google Scholar和Science Direct等数据库,我们找到了符合meta分析条件的研究。利用一些生物信息学工具检测rs2232365和rs3761548多态性对FOXP3基因功能的影响。结果:我们的数据显示rs3761548多态性与PE风险降低之间存在显著关联。此外,我们观察到rs2232365与轻度先兆子痫风险增加之间存在显著关联。此外,我们的生物信息学分析显示rs2232365和rs3761548多态性都可能影响FOXP3基因的功能。结论:基于我们的研究结果,rs3761548基因变异可能是PE风险的保护因素。而rs2232365多态性可能是轻度子痫前期的遗传风险因素。因此,作为一项初步研究,这些遗传变异可以被认为是PE疾病的分子生物标志物。
{"title":"Influence of FOXP3 gene polymorphisms on the risk of preeclampsia: a meta-analysis and a bioinformatic approach.","authors":"Mohammad Karimian,&nbsp;Saeedeh Ghazaey Zidanloo,&nbsp;Danial Jahantigh","doi":"10.1080/10641963.2021.2022685","DOIUrl":"https://doi.org/10.1080/10641963.2021.2022685","url":null,"abstract":"<p><strong>Background and aim: </strong>Preeclampsia (PE), a multifactorial disorder, is the main cause of maternal mortality and morbidity. Genetic polymorphisms in key proteins involved in the immune system may change the risk of PE risk. In this study, we examined the association of two rs2232365 and rs3761548 common polymorphisms of the FOXP3 immune response gene with PE susceptibility by a meta-analysis which was followed by an in-silico analysis.</p><p><strong>Materials and methods: </strong>Through a systematic search in databases including PubMed, MEDLINE, Google Scholar, and Science Direct, we find eligible studies for meta-analysis. Some bioinformatics tools were used to detect the impact of rs2232365 and rs3761548 polymorphisms on the FOXP3 gene function.</p><p><strong>Results: </strong>Our data revealed that there is a significant association between rs3761548 polymorphism and decreased risk of PE. In addition, we observed a significant association between rs2232365 and increased risk of mild preeclampsia. Also, our bioinformatic analysis showed that both rs2232365 and rs3761548 polymorphisms could affect FOXP3 gene function.</p><p><strong>Conclusion: </strong>Based on our findings, the rs3761548 genetic variation could be a protective factor against PE risk. While the rs2232365 polymorphism may be a genetic risk factor for mild preeclampsia. Therefore, as a preliminary study, these genetic variations could be considered molecular biomarkers for PE disorder.</p>","PeriodicalId":10333,"journal":{"name":"Clinical and Experimental Hypertension","volume":null,"pages":null},"PeriodicalIF":12.3,"publicationDate":"2022-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39809649","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Insertion/deletion polymorphism at angiotensin-converting enzyme gene in PTSD individuals and their reciprocal effects on blood pressure. PTSD患者血管紧张素转换酶基因的插入/缺失多态性及其对血压的影响。
IF 12.3 4区 医学 Q3 Medicine Pub Date : 2022-04-03 Epub Date: 2021-12-22 DOI: 10.1080/10641963.2021.2018598
Ling Nan Kong, Yi Lin Shen, Yong Li Chen, Xu Chen, Guo Ming Su, Jin Hua Wang, Gui Bang Xiao, Qi Wei Guo, Ji Cheng Zhang, Ding Zhi Fang, Jia Lin

Objectives: The aim of the present study was to investigate relationships between insertion/deletion (I/D) polymorphism at angiotensin-converting enzyme gene (ACE) and post-traumatic stress disorder (PTSD), as well as their interactions on blood pressure.

Methods: Variants of ACE I/D were identified by polymerase chain reaction method and verified by DNA sequencing. PTSD symptoms were assessed by the PTSD Checklist-Civilian Version (PCL-C) based on DSM-IV-TR criteria among high school students at 6 months after the 2008 Wenchuan earthquake.

Results: Female subjects were found to have higher prevalence of PTSD and PCL-C scores than male counterparts in the II homozygotes (p = .038 for PTSD and p = .003 for PCL-C scores) and the ID heterozygotes (p = .000 for PTSD and p = .000 for PCL-C scores), but not in the DD homozygotes. Male subjects with the ID (p = .046) or the DD genotype (p = .039) had lower pulse pressure (PP) than the male II homozygotes, while the female II homozygotes had lower diastolic blood pressure (DBP) than the female DD homozygotes (p = .036). ACE I/D, PTSD, or PCL-C scores, as well as gender and BMI, were found to be the predictors of PP.

Conclusions: These results indicate that there are interactions of ACE I/D and PTSD, together with gender and BMI, on PP. This finding may be the additional explanation for the heterogeneous relationships between PTSD and blood pressure, and suggest psychiatry care and different medication strategies for patients with comorbidities of PTSD and hypertension and with different genotypes of ACE I/D.

目的:探讨血管紧张素转换酶基因(ACE)插入/缺失(I/D)多态性与创伤后应激障碍(PTSD)的关系及其与血压的相互作用。方法:采用聚合酶链反应法鉴定ACE I/D变异,并进行DNA测序验证。采用基于DSM-IV-TR标准的PTSD平民版(PCL-C)量表对2008年汶川地震后6个月高中生的PTSD症状进行评估。结果:在II型纯合子(PTSD p = 0.038, PCL-C p = 0.003)和ID型杂合子(PTSD p = 0.000, PCL-C p = 0.000)中,女性受试者的PTSD患病率和PCL-C评分高于男性受试者,而在DD型纯合子中则没有。男性ID (p = 0.046)或DD基因型(p = 0.039)的脉搏压(PP)低于男性II型纯合子,女性II型纯合子的舒张压(DBP)低于女性DD型纯合子(p = 0.036)。ACE I/D、PTSD或PCL-C评分以及性别和BMI均可作为PP的预测因子。结论:这些结果表明,ACE I/D、PTSD、性别和BMI对PP有相互作用,这一发现可能是PTSD与血压异质性关系的补充解释,并为不同基因型的PTSD合并高血压患者提供精神病学护理和不同的药物治疗策略。
{"title":"Insertion/deletion polymorphism at angiotensin-converting enzyme gene in PTSD individuals and their reciprocal effects on blood pressure.","authors":"Ling Nan Kong,&nbsp;Yi Lin Shen,&nbsp;Yong Li Chen,&nbsp;Xu Chen,&nbsp;Guo Ming Su,&nbsp;Jin Hua Wang,&nbsp;Gui Bang Xiao,&nbsp;Qi Wei Guo,&nbsp;Ji Cheng Zhang,&nbsp;Ding Zhi Fang,&nbsp;Jia Lin","doi":"10.1080/10641963.2021.2018598","DOIUrl":"https://doi.org/10.1080/10641963.2021.2018598","url":null,"abstract":"<p><strong>Objectives: </strong>The aim of the present study was to investigate relationships between insertion/deletion (<i>I/D</i>) polymorphism at angiotensin-converting enzyme gene (<i>ACE</i>) and post-traumatic stress disorder (PTSD), as well as their interactions on blood pressure.</p><p><strong>Methods: </strong>Variants of <i>ACE I/D</i> were identified by polymerase chain reaction method and verified by DNA sequencing. PTSD symptoms were assessed by the PTSD Checklist-Civilian Version (PCL-C) based on DSM-IV-TR criteria among high school students at 6 months after the 2008 Wenchuan earthquake.</p><p><strong>Results: </strong>Female subjects were found to have higher prevalence of PTSD and PCL-C scores than male counterparts in the II homozygotes (<i>p</i> = .038 for PTSD and <i>p</i> = .003 for PCL-C scores) and the ID heterozygotes (<i>p</i> = .000 for PTSD and <i>p</i> = .000 for PCL-C scores), but not in the DD homozygotes. Male subjects with the ID (<i>p</i> = .046) or the DD genotype (<i>p</i> = .039) had lower pulse pressure (PP) than the male II homozygotes, while the female II homozygotes had lower diastolic blood pressure (DBP) than the female DD homozygotes (<i>p</i> = .036). <i>ACE I/D</i>, PTSD, or PCL-C scores, as well as gender and BMI, were found to be the predictors of PP.</p><p><strong>Conclusions: </strong>These results indicate that there are interactions of <i>ACE I/D</i> and PTSD, together with gender and BMI, on PP. This finding may be the additional explanation for the heterogeneous relationships between PTSD and blood pressure, and suggest psychiatry care and different medication strategies for patients with comorbidities of PTSD and hypertension and with different genotypes of <i>ACE I/D</i>.</p>","PeriodicalId":10333,"journal":{"name":"Clinical and Experimental Hypertension","volume":null,"pages":null},"PeriodicalIF":12.3,"publicationDate":"2022-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39746097","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current prescription status of antihypertensive drugs in Chinese patients with hypertension: analysis by type of comorbidities. 中国高血压患者降压药处方现状:合并症类型分析
IF 12.3 4区 医学 Q3 Medicine Pub Date : 2022-04-03 Epub Date: 2022-01-03 DOI: 10.1080/10641963.2021.2022688
Renren Yang, Jia Tang, Yunping Zhuo, Ming Kuang, Hongying Liu

In 2020, the National Center for Cardiovascular Diseases with National Committee on Hypertension Management in Primary Health Care in China issued revised national clinical practice guidelines on the management of hypertension in primary health care based on the 2018 Chinese guidelines for the management of hypertension. To evaluate adherence to the guidelines, this retrospective study assessed the real-world status of antihypertensive drug prescribing for Chinese patients with hypertension, classified by comorbidity: coronary heart disease, diabetes mellitus, heart failure, stroke, and renal disease. About 1088212 hypertensive patients who received their first prescription for antihypertensive therapy between January 2021 to June 2021, were obtained from a database of Hangzhou Kang Sheng Health Consulting CO., Ltd. Calcium channel blockers (CCBs) and angiotensin II receptor blockers (ARBs) were the most common drugs prescribed for each comorbidity subgroup. Whereas diabetes mellitus or renal disease is a compelling indication for use of renin-angiotensin system inhibitors, CCBs were often administered in these subgroups. The treatment pattern for patients with coronary heart disease was closely similar to that for the overall patient population. Beta-blockers (BBs) were prescribed more frequently for patients with heart failure than for those with other comorbidities. Although antihypertensive drug prescription varied by comorbidity, pharmacological decisions were largely made under Chinese recommendations while physicians could select antihypertensive drugs based on the patients' comorbidities. However, educational initiatives are still necessary to inspire clinicians to better familiarize themselves with the guidelines and manage hypertension comorbid diseases.

2020年,国家心血管疾病中心联合全国初级卫生保健高血压管理专业委员会,在2018年《中国高血压管理指南》的基础上,修订了国家初级卫生保健高血压管理临床实践指南。为了评估指南的依从性,本回顾性研究评估了中国高血压患者抗高血压药物处方的现实状况,并根据合并症进行了分类:冠心病、糖尿病、心力衰竭、中风和肾脏疾病。从杭州康盛健康咨询有限公司数据库中获取2021年1月至2021年6月首次接受降压治疗的高血压患者约1088212例。钙通道阻滞剂(CCBs)和血管紧张素受体阻滞剂(ARBs)是各合并症亚组最常用的处方药物。鉴于糖尿病或肾脏疾病是使用肾素-血管紧张素系统抑制剂的一个令人信服的适应症,CCBs通常在这些亚组中使用。冠心病患者的治疗模式与总体患者人群的治疗模式非常相似。-受体阻滞剂(BBs)用于心力衰竭患者的频率高于其他合并症患者。尽管抗高血压药物处方因合并症而异,但药理学决策主要是根据中国的建议做出的,而医生可以根据患者的合并症选择抗高血压药物。然而,教育倡议仍然是必要的,以激励临床医生更好地熟悉指南和管理高血压合并症疾病。
{"title":"Current prescription status of antihypertensive drugs in Chinese patients with hypertension: analysis by type of comorbidities.","authors":"Renren Yang,&nbsp;Jia Tang,&nbsp;Yunping Zhuo,&nbsp;Ming Kuang,&nbsp;Hongying Liu","doi":"10.1080/10641963.2021.2022688","DOIUrl":"https://doi.org/10.1080/10641963.2021.2022688","url":null,"abstract":"<p><p>In 2020, the National Center for Cardiovascular Diseases with National Committee on Hypertension Management in Primary Health Care in China issued revised national clinical practice guidelines on the management of hypertension in primary health care based on the 2018 Chinese guidelines for the management of hypertension. To evaluate adherence to the guidelines, this retrospective study assessed the real-world status of antihypertensive drug prescribing for Chinese patients with hypertension, classified by comorbidity: coronary heart disease, diabetes mellitus, heart failure, stroke, and renal disease. About 1088212 hypertensive patients who received their first prescription for antihypertensive therapy between January 2021 to June 2021, were obtained from a database of Hangzhou Kang Sheng Health Consulting CO., Ltd. Calcium channel blockers (CCBs) and angiotensin II receptor blockers (ARBs) were the most common drugs prescribed for each comorbidity subgroup. Whereas diabetes mellitus or renal disease is a compelling indication for use of renin-angiotensin system inhibitors, CCBs were often administered in these subgroups. The treatment pattern for patients with coronary heart disease was closely similar to that for the overall patient population. Beta-blockers (BBs) were prescribed more frequently for patients with heart failure than for those with other comorbidities. Although antihypertensive drug prescription varied by comorbidity, pharmacological decisions were largely made under Chinese recommendations while physicians could select antihypertensive drugs based on the patients' comorbidities. However, educational initiatives are still necessary to inspire clinicians to better familiarize themselves with the guidelines and manage hypertension comorbid diseases.</p>","PeriodicalId":10333,"journal":{"name":"Clinical and Experimental Hypertension","volume":null,"pages":null},"PeriodicalIF":12.3,"publicationDate":"2022-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39777688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The relationship between mean platelet volume and resistant hypertension. 平均血小板体积与顽固性高血压的关系。
IF 12.3 4区 医学 Q3 Medicine Pub Date : 2022-04-03 Epub Date: 2022-01-03 DOI: 10.1080/10641963.2021.2022686
Halil Akın, Önder Bilge, Bünyamin Yavuz, Selçuk Özkan, Ferhat Işık

Objective: Resistant hypertension (RH) is associated with an increased risk of cardiovascular events.Mean platelet volume (MPV) has been shown to indicate platelet activation and is associated with increased cardiovascular disease risk. In our study, we aimed to evaluate the relationship between mean platelet volume and resistant hypertension.

Method: A total of 279 patientswere included in our study and divided into three groups (GroupI: seventy-eight patients with resistant hypertension, group II: seventy-nine patients with controlled hypertension and group III: one-hundred-five patients without hypertension). Routine laboratory tests and ambulatory blood pressure measurement (ABPM) were followed up in all patients.

Results: Of the patients in the study, 25% were female while 75% were male, and the mean age was 56.5 ± 11.8 years. The mean MPV values were found to be 9.34 ± 1.49 fL in the RHT group, 8.82 ± 0.83 fLin the controlled HT group, and 8.5 ± 0.85 fL in the normotensive individuals, and there was a significant correlation between the RHT group and the other groups (RHT versus controlled HT p1 = 0.008, RHT versus normotensive individuals p2 < 0,001). When we compared controlled HT and normotensive individuals, no significant relationship was found between MPV values (p3 = 0,157).

Conclusion: The MPV value was found to be higher in resistant hypertensive patients compared to controlled hypertensive and normotensive patients. MPV values can be used to predict adverse cardiovascular events in RHT patients.

目的:顽固性高血压(RH)与心血管事件风险增加相关。平均血小板体积(MPV)显示血小板活化,并与心血管疾病风险增加有关。在我们的研究中,我们旨在评估平均血小板体积与顽固性高血压的关系。方法:将279例患者分为3组(顽固性高血压患者78例,控制高血压患者79例,无高血压患者105例)。随访所有患者的常规实验室检查和动态血压测量(ABPM)。结果:本组患者中女性占25%,男性占75%,平均年龄56.5±11.8岁。RHT组MPV均值为9.34±1.49 fL,对照组为8.82±0.83 fL,正常血压组为8.5±0.85 fL,且与其他组有显著相关性(RHT与对照组p1 = 0.008, RHT与正常血压组p2)。结论:高血压抵抗组MPV值高于高血压控制组和正常血压组。MPV值可用于预测RHT患者的不良心血管事件。
{"title":"The relationship between mean platelet volume and resistant hypertension.","authors":"Halil Akın,&nbsp;Önder Bilge,&nbsp;Bünyamin Yavuz,&nbsp;Selçuk Özkan,&nbsp;Ferhat Işık","doi":"10.1080/10641963.2021.2022686","DOIUrl":"https://doi.org/10.1080/10641963.2021.2022686","url":null,"abstract":"<p><strong>Objective: </strong>Resistant hypertension (RH) is associated with an increased risk of cardiovascular events.Mean platelet volume (MPV) has been shown to indicate platelet activation and is associated with increased cardiovascular disease risk. In our study, we aimed to evaluate the relationship between mean platelet volume and resistant hypertension.</p><p><strong>Method: </strong>A total of 279 patientswere included in our study and divided into three groups (GroupI: seventy-eight patients with resistant hypertension, group II: seventy-nine patients with controlled hypertension and group III: one-hundred-five patients without hypertension). Routine laboratory tests and ambulatory blood pressure measurement (ABPM) were followed up in all patients.</p><p><strong>Results: </strong>Of the patients in the study, 25% were female while 75% were male, and the mean age was 56.5 ± 11.8 years. The mean MPV values were found to be 9.34 ± 1.49 fL in the RHT group, 8.82 ± 0.83 fLin the controlled HT group, and 8.5 ± 0.85 fL in the normotensive individuals, and there was a significant correlation between the RHT group and the other groups (RHT versus controlled HT p1 = 0.008, RHT versus normotensive individuals p2 < 0,001). When we compared controlled HT and normotensive individuals, no significant relationship was found between MPV values (p3 = 0,157).</p><p><strong>Conclusion: </strong>The MPV value was found to be higher in resistant hypertensive patients compared to controlled hypertensive and normotensive patients. MPV values can be used to predict adverse cardiovascular events in RHT patients.</p>","PeriodicalId":10333,"journal":{"name":"Clinical and Experimental Hypertension","volume":null,"pages":null},"PeriodicalIF":12.3,"publicationDate":"2022-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39780070","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Effect of prior beta-blocker use on in-hospital atrial fibrillation development in patients with ST-elevation myocardial infarction. 既往使用受体阻滞剂对st段抬高型心肌梗死患者住院房颤发展的影响
IF 12.3 4区 医学 Q3 Medicine Pub Date : 2022-04-03 Epub Date: 2022-01-30 DOI: 10.1080/10641963.2022.2029473
Fatih Kahraman, Akif Arslan, Abdullah Dogan, Yasin Turker, Serdar Guler

Background and aim: There are conflicting results about the early administration of beta-blockers (bb) on in-hospital mortality and arrhythmias. Here, we wanted to investigate the effects of chronic bb use on in-hospital Atrial Fibrillation (AF) development in ST-Elevation Myocardial Infarction (STEMI) patients.

Materials and methods: A total of 814 consecutive patients with STEMI were included in the study. They were divided into two groups according to whether they are using bb on admission or not. They were followed for AF development in-hospital and predictors of AF were determined by multivariable logistic regression analysis.

Results: Of the 814 patients, 103 (12.67%) patients were already using bb, while 711 (87.3%) were not. There were no significant differences in the frequency of AF development [3 (%2.9) vs 30 (%4.2), p = .788] between the groups. Multivariable logistic regression analysis showed that left atrial (LA) diameter is the only independent predictor of in-hospital AF development.

Conclusions: Our study showed that chronic bb use does not have an effect on in-hospital AF development in STEMI patients. Nevertheless, LA diameter was found to be an independent predictor of AF.

背景和目的:关于早期使用β受体阻滞剂(bb)对住院死亡率和心律失常的影响,有相互矛盾的结果。在这里,我们想研究慢性bb使用对st段抬高型心肌梗死(STEMI)患者住院房颤(AF)发展的影响。材料和方法:共纳入814例连续STEMI患者。根据入院时是否使用bb,他们被分为两组。随访患者的房颤发展情况,并通过多变量logistic回归分析确定房颤的预测因素。结果:814例患者中,103例(12.67%)患者已使用bb, 711例(87.3%)患者未使用bb。两组间房颤发生频率无显著差异[3 (%2.9)vs 30 (%4.2), p = .788]。多变量logistic回归分析显示左心房内径是院内房颤发生的唯一独立预测因子。结论:我们的研究表明,慢性bb使用对STEMI患者的住院房颤发展没有影响。然而,发现左室直径是房颤的独立预测因子。
{"title":"Effect of prior beta-blocker use on in-hospital atrial fibrillation development in patients with ST-elevation myocardial infarction.","authors":"Fatih Kahraman,&nbsp;Akif Arslan,&nbsp;Abdullah Dogan,&nbsp;Yasin Turker,&nbsp;Serdar Guler","doi":"10.1080/10641963.2022.2029473","DOIUrl":"https://doi.org/10.1080/10641963.2022.2029473","url":null,"abstract":"<p><strong>Background and aim: </strong>There are conflicting results about the early administration of beta-blockers (bb) on in-hospital mortality and arrhythmias. Here, we wanted to investigate the effects of chronic bb use on in-hospital Atrial Fibrillation (AF) development in ST-Elevation Myocardial Infarction (STEMI) patients.</p><p><strong>Materials and methods: </strong>A total of 814 consecutive patients with STEMI were included in the study. They were divided into two groups according to whether they are using bb on admission or not. They were followed for AF development in-hospital and predictors of AF were determined by multivariable logistic regression analysis.</p><p><strong>Results: </strong>Of the 814 patients, 103 (12.67%) patients were already using bb, while 711 (87.3%) were not. There were no significant differences in the frequency of AF development [3 (%2.9) vs 30 (%4.2), p = .788] between the groups. Multivariable logistic regression analysis showed that left atrial (LA) diameter is the only independent predictor of in-hospital AF development.</p><p><strong>Conclusions: </strong>Our study showed that chronic bb use does not have an effect on in-hospital AF development in STEMI patients. Nevertheless, LA diameter was found to be an independent predictor of AF.</p>","PeriodicalId":10333,"journal":{"name":"Clinical and Experimental Hypertension","volume":null,"pages":null},"PeriodicalIF":12.3,"publicationDate":"2022-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39874077","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Clinical and Experimental Hypertension
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1